Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20
Phase 2
Completed
- Conditions
- Opioid-Related Disorders
- Registration Number
- NCT00000238
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Brief Summary
The purpose of this study is to assess the degree in which opioid-dependent outpatients discount the value of an additional maintenance dose of buprenorphine under differing states of opioid deprivation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Drug use Money choice Heroin craving
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie buprenorphine's delayed outcomes in opioid-dependent outpatients?
How does buprenorphine maintenance compare to methadone in managing opioid-related disorders?
Are there specific biomarkers that predict response to buprenorphine in opioid-dependent patients?
What adverse events are associated with buprenorphine maintenance therapy in outpatient settings?
What combination therapies or alternative opioid antagonists show promise in treating opioid-related disorders?
Trial Locations
- Locations (1)
Treatment Research Center
🇺🇸Burlington, Vermont, United States
Treatment Research Center🇺🇸Burlington, Vermont, United States